Home Cart 0 Sign in  

[ CAS No. 122-18-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 122-18-9
Chemical Structure| 122-18-9
Structure of 122-18-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 122-18-9 ]

Related Doc. of [ 122-18-9 ]

Alternatived Products of [ 122-18-9 ]

Product Details of [ 122-18-9 ]

CAS No. :122-18-9 MDL No. :MFCD00011625
Formula : C25H46ClN Boiling Point : -
Linear Structure Formula :- InChI Key :SXPWTBGAZSPLHA-UHFFFAOYSA-M
M.W : 396.09 Pubchem ID :31202
Synonyms :
Benzyldimethylhexadecylammonium chloride
Chemical Name :N-Benzyl-N,N-dimethylhexadecan-1-aminium chloride

Calculated chemistry of [ 122-18-9 ]

Physicochemical Properties

Num. heavy atoms : 27
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.76
Num. rotatable bonds : 17
Num. H-bond acceptors : 0.0
Num. H-bond donors : 0.0
Molar Refractivity : 126.16
TPSA : 0.0 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -1.38 cm/s

Lipophilicity

Log Po/w (iLOGP) : -1.17
Log Po/w (XLOGP3) : 10.33
Log Po/w (WLOGP) : 4.6
Log Po/w (MLOGP) : 2.64
Log Po/w (SILICOS-IT) : 7.82
Consensus Log Po/w : 4.84

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 1.0
Egan : 0.0
Muegge : 3.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -7.85
Solubility : 0.00000565 mg/ml ; 0.0000000143 mol/l
Class : Poorly soluble
Log S (Ali) : -10.27
Solubility : 0.0000000212 mg/ml ; 0.0000000001 mol/l
Class : Insoluble
Log S (SILICOS-IT) : -10.04
Solubility : 0.0000000359 mg/ml ; 0.0000000001 mol/l
Class : Insoluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 2.68

Safety of [ 122-18-9 ]

Signal Word:Danger Class:8
Precautionary Statements:P273-P280-P305+P351+P338-P310 UN#:3261
Hazard Statements:H302+H312-H314-H410 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 122-18-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 122-18-9 ]
  • Downstream synthetic route of [ 122-18-9 ]

[ 122-18-9 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 112-69-6 ]
  • [ 100-44-7 ]
  • [ 122-18-9 ]
Reference: [1] Yakugaku Zasshi, 1943, vol. 63, p. 589[2] Chem.Abstr., 1951, p. 5100
[3] Patent: US2075958, 1934, ,
[4] Berichte der Bunsengesellschaft/Physical Chemistry Chemical Physics, 1990, vol. 94, # 8, p. 882 - 887
[5] Pharmaceutical Chemistry Journal, 1984, vol. 18, # 11, p. 784 - 787[6] Khimiko-Farmatsevticheskii Zhurnal, 1984, vol. 18, # 11, p. 1344 - 1348
[7] Berichte der Bunsengesellschaft/Physical Chemistry Chemical Physics, 1996, vol. 100, # 7, p. 1147 - 1152
[8] Physical Chemistry Chemical Physics, 1999, vol. 1, # 8, p. 1957 - 1964
[9] Journal of Physical Organic Chemistry, 1999, vol. 12, # 4, p. 325 - 332
[10] Revue Roumaine de Chimie, 2001, vol. 46, # 1, p. 49 - 53
[11] Revue Roumaine de Chimie, 2001, vol. 46, # 1, p. 49 - 53
[12] Antimicrobial Agents and Chemotherapy, 2002, vol. 46, # 5, p. 1469 - 1474
[13] Patent: CN106946716, 2017, A, . Location in patent: Paragraph 0018; 0023
[14] Patent: CN106916071, 2017, A, . Location in patent: Paragraph 0019; 0020; 0023; 0024
  • 2
  • [ 36653-82-4 ]
  • [ 122-18-9 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1984, vol. 18, # 11, p. 784 - 787[2] Khimiko-Farmatsevticheskii Zhurnal, 1984, vol. 18, # 11, p. 1344 - 1348
  • 3
  • [ 100-44-7 ]
  • [ 30912-93-7 ]
  • [ 140-11-4 ]
  • [ 122-18-9 ]
Reference: [1] Journal of the American Chemical Society, 1983, vol. 105, # 6, p. 1567 - 1571
  • 4
  • [ 4860-03-1 ]
  • [ 122-18-9 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1984, vol. 18, # 11, p. 784 - 787[2] Khimiko-Farmatsevticheskii Zhurnal, 1984, vol. 18, # 11, p. 1344 - 1348
  • 5
  • [ 103-83-3 ]
  • [ 4860-03-1 ]
  • [ 122-18-9 ]
Reference: [1] Chemische Berichte, 1940, vol. 73, p. 1007
Same Skeleton Products
Historical Records